CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
To learn if cemiplimab can help to control dMMR colon cancer....
Phase 2
Camden, New Jersey, United States and 4 other locations
and irinotecan) in participants with metastatic colorectal cancer (mCRC). The main goals of this study are to:* Evaluate the efficacy of the...
Phase 2
Wynnewood, Pennsylvania, United States and 13 other locations
Solid tumours are abnormal lumps of tissue that can occur in different parts of the body. The tumours involved in this study have specific genetic ch...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 21 other locations
to participants with advanced solid tumors, including rearranged during transfection (RET)-fusion-positive solid tumors, medullary thyroid cancer...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 85 other locations
the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon...
Phase 2, Phase 3
Philadelphia, Pennsylvania, United States and 1076 other locations
This is an open-label, multi-center Phase 1/2 study of oral LOXO-292 in pediatric participants with an activating rearranged during transfection (RET...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 25 other locations
with either (a) hepatocellular carcinoma (HCC) that is not amenable to resection, transplant or other potentially curative therapy or (b) cancer...
Phase 1
Bethlehem, Pennsylvania, United States and 4 other locations
chemotherapy and bevacizumab with or without INCA33890 in the first-line treatment of metastatic microsatellite stable colorectal cancer....
Phase 3
Philadelphia, Pennsylvania, United States and 256 other locations
This is a Phase 1/2 study to assess the safety and efficacy of ELI-002 7P immunotherapy (a lipid-conjugated immune-stimulatory oligonucleotide \[Amph...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 27 other locations
This study will evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 (adagrasib) in patients with adva...
Phase 1, Phase 2
Media, Pennsylvania, United States and 231 other locations
Clinical trials
Research sites
Resources
Legal